Point72 Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$3.99M Sell
2023
Q4
$14.5M Buy
2023
Q3
$1.05M Buy